Autoimmunity and long-term safety and efficacy of alemtuzumab for multiple sclerosis: Benefit/risk following review of trial and post-marketing dataShort Report Published on 2021-12-092024-09-04 Journal: Multiple Sclerosis Journal [Category] 대상포진, [키워드] Alemtuzumab Autoimmunity multiple sclerosis Post-marketing product surveillance Risk assessment Treatment outcome [DOI] 10.1177/13524585211061335 PMC 바로가기 [Article Type] Short Report
Drug Induced Liver Injury: Perspective of the Adverse Drug Reaction Reports to the Portuguese Pharmacovigilance System from 2010 to 2019Article Published on 2021-11-252023-08-30 Journal: International journal for equity in health [Category] E형 간염, [키워드] adverse drug reaction reporting systems drug induced liver diseases pharmacovigilance system Post-marketing product surveillance [DOI] 10.3390/healthcare9121630 PMC 바로가기 [Article Type] Article
Updates on Vaccine Safety and Post-Licensure Surveillance for Adverse Events Following Immunization in South Korea, 2005–2017Original Article Published on 2020-07-012024-09-04 Journal: Yonsei medical journal [Category] 대상포진, [키워드] adverse drug reaction reporting systems drug-related side effects and adverse reactions Postmarketing product surveillance signal detection Vaccines [DOI] 10.3349/ymj.2020.61.7.623 PMC 바로가기 [Article Type] Original Article